findmyKOL
Clinical trialNCT01083186CompletedObservational

Paricalcitol Oral Therapy in Predialysis CKD Patients. The Greek Experience

SponsorAbbVie (prior sponsor, Abbott)Enrollment500Chronic Kidney FailureSecondary Hyperparathyroidism
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to obtain data on the use of Zemplar (paricalcitol) capsules in real-life clinical practice in predialysis patients with chronic kidney disease (CKD) and secondary hyperparathyroidism.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Greece
  • Site Reference Id/investigator# 47002

    Arta, Greece

  • Site Reference Id/investigator# 27489

    Athens, Greece

  • Site Reference Id/investigator# 27492

    Athens, Greece

  • Site Reference Id/investigator# 27495

    Athens, Greece

  • Site Reference Id/investigator# 27497

    Athens, Greece

  • Site Reference Id/investigator# 38257

    Athens, Greece

  • Site Reference Id/investigator# 43769

    Athens, Greece

  • Site Reference Id/investigator# 43772

    Athens, Greece

  • Site Reference Id/investigator# 43773

    Athens, Greece

  • Site Reference Id/investigator# 47003

    Athens, Greece

  • Site Reference Id/investigator# 47004

    Athens, Greece

  • Site Reference Id/investigator# 27498

    Haidari, Athens, Greece

  • Site Reference Id/investigator# 38259

    Ioannina, Greece

  • Site Reference Id/investigator# 22121

    Larissa, Greece

  • Site Reference Id/investigator# 43771

    Larissa, Greece

  • Site Reference Id/investigator# 43767

    Maroussi Athens, Greece

  • Site Reference Id/investigator# 27496

    Nikaia, Greece

  • Site Reference Id/investigator# 43768

    North Ionia, Athens, Greece

  • Site Reference Id/investigator# 27491

    Piraeus, Greece

  • Site Reference Id/investigator# 27493

    Thessaloniki, Greece

  • Site Reference Id/investigator# 27494

    Thessaloniki, Greece

  • Site Reference Id/investigator# 38255

    Thessaloniki, Greece

  • Site Reference Id/investigator# 39839

    Thessaloniki, Greece

  • Site Reference Id/investigator# 43770

    Thessaloniki, Greece

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2009
Primary completion
31 Jan 2012
Completion
31 Jan 2012
Last update posted
12 Mar 2013
Registered enrollment
500
Registry id
NCT01083186
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.